P3 Health Partners (PIII) | Stock Overview & Key Data
P3 Health Partners Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $16.89 on May 28, 2026
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
P3 Health Partners
PIII
|
551.61M Small-cap | -4.57% | 3.54% | 284.54% | 136.16% | 234.00% | 83.08% | -93.73% | -97.55% | -97.50% | -97.50% | -97.50% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | 9.88% | -8.92% | -18.33% | -9.23% | -10.20% | 6.26% | 122.70% | 164.92% | 543.08% | 581.20% | 489.27% |
|
Surgery Partners
SGRY
|
1.86B Small-cap | 9.24% | 8.46% | 22.11% | -2.01% | -0.85% | -32.67% | -62.68% | -76.34% | -2.17% | -16.93% | -16.93% |
| 1.91B Small-cap | 8.46% | 8.36% | 25.04% | 7.40% | 14.47% | 73.57% | 75.20% | -20.69% | -64.71% | -31.34% | 9.12% | |
|
Astrana Health
ASTH
|
1.88B Small-cap | -0.03% | 0.31% | 56.02% | 72.11% | 52.18% | 49.98% | 24.10% | -27.77% | 642.69% | 657.25% | 657.25% |
Ownership & Short Interest
Calculate Your P3 Health Partners Investment Returns
Long-Term Investment Performance Analysis
P3 Health Partners stock price in Apr 2021 was $488.50, A $1,000.00 lump sum investment in P3 Health Partners made 5 years ago would be worth approximately $23.93 today, representing a negative return of -97.61%. This translates to an annualized return (CAGR) of -51.26%.
5 Years 2 Months Investment Scenario (Apr 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PIII's 52-week high and low?
- In the last 52 weeks, P3 Health Partners reached a high of $16.89 (on May 28, 2026) and a low of $1.52 (on February 2, 2026).
- What is the market cap and P/E ratio for PIII?
- Curious about P3 Health Partners's size and valuation? Its market capitalization stands at 551.61M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.06, and the forward P/E (looking ahead) is -12.93.
- Does PIII pay dividends? If so, what's the yield?
- As for dividends, P3 Health Partners isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are P3 Health Partners's main competitors or similar companies to consider before investing?
When looking at P3 Health Partners, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities 4.31% 33.47% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 6.26% 122.70% Surgery Partners
SGRY1.86B Healthcare Medical Care Facilities -32.67% -62.68% Pediatrix Medical
MD1.91B Healthcare Medical Care Facilities 73.57% 75.20% Astrana Health
ASTH1.88B Healthcare Medical Care Facilities 49.98% 24.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for P3 Health Partners Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of P3 Health Partners's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -6,952.57%, the Debt to Equity ratio from the most recent quarter is -2.05, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for PIII?
- Looking at P3 Health Partners's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.80%, and quarterly earnings saw a YoY growth of 3.81%.
- How much of PIII stock is held by insiders and institutions?
- Wondering who owns P3 Health Partners stock? Company insiders (like executives and directors) hold about 51.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.86%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.